Monastirioti, A.; Papadaki, C.; Kalapanida, D.; Rounis, K.; Michaelidou, K.; Papadaki, M.A.; Mavroudis, D.; Agelaki, S.
Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab. Cancers 2022, 14, 4739.
https://doi.org/10.3390/cancers14194739
AMA Style
Monastirioti A, Papadaki C, Kalapanida D, Rounis K, Michaelidou K, Papadaki MA, Mavroudis D, Agelaki S.
Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab. Cancers. 2022; 14(19):4739.
https://doi.org/10.3390/cancers14194739
Chicago/Turabian Style
Monastirioti, Alexia, Chara Papadaki, Despoina Kalapanida, Konstantinos Rounis, Kleita Michaelidou, Maria A. Papadaki, Dimitrios Mavroudis, and Sofia Agelaki.
2022. "Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab" Cancers 14, no. 19: 4739.
https://doi.org/10.3390/cancers14194739
APA Style
Monastirioti, A., Papadaki, C., Kalapanida, D., Rounis, K., Michaelidou, K., Papadaki, M. A., Mavroudis, D., & Agelaki, S.
(2022). Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab. Cancers, 14(19), 4739.
https://doi.org/10.3390/cancers14194739